Monica Gatti

发表

Adiponectin as Novel Regulator of Cell Proliferation in Human Glioblastoma

A. Di Costanzo, A. Bajetto, T. Florio, 2014, Journal of cellular physiology.

Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.

P. Fiaschi, Roberto Würth, A. Bajetto, 2013, Toxicology.

Metformin selectively affects human glioblastoma tumor-initiating cell viability

G. Sambuceti, Roberto Würth, T. Florio, 2013, Cell Cycle.

Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets.

A. Ratto, Roberto Würth, A. Bajetto, 2011, Biochemical pharmacology.

Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation.

L. Mutti, L. Paleari, A. Bajetto, 2010, Current cancer drug targets.

Balance between somatostatin and D2 receptor expression drives TSH‐secreting adenoma response to somatostatin analogues and dopastatins

S. Schulz, M. Culler, F. Minuto, 2012, Clinical endocrinology.

Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.

M. Culler, A. Bajetto, T. Florio, 2009, American journal of physiology. Endocrinology and metabolism.

SDF‐1 Controls Pituitary Cell Proliferation through the Activation of ERK1/2 and the Ca2+‐Dependent, Cytosolic Tyrosine Kinase Pyk2

M. Robello, S. Arena, G. Schettini, 2006, Annals of the New York Academy of Sciences.

Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.

M. Culler, A. Bajetto, T. Florio, 2008, Endocrinology.

Minimalist hybrid ligand/receptor-based pharmacophore model for CXCR4 applied to a small-library of marine natural products led to the identification of phidianidine a as a new CXCR4 ligand exhibiting antagonist activity.

Rosa Maria Vitale, Pietro Amodeo, R. Vitale, 2013, ACS chemical biology.

In vitro and in vivo characterization of stem‐like cells from canine osteosarcoma and assessment of drug sensitivity

A. Ratto, Roberto Würth, S. Thellung, 2018, Experimental cell research.

Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells

A. Pagano, Roberto Würth, S. Thellung, 2016, Oncotarget.

In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors

F. Mattioli, A. Pagano, A. Ratto, 2015, BMC Cancer.

Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors*

Gianluigi Zona, A. Bajetto, T. Florio, 2009, Journal of Biological Chemistry.

Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm

Roberto Würth, S. Thellung, A. Bajetto, 2013, International journal of peptides.

In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors

F. Mattioli, A. Pagano, A. Ratto, 2015, BMC Cancer.

17β-Estradiol Promotes Breast Cancer Cell Proliferation-Inducing Stromal Cell-Derived Factor-1-Mediated Epidermal Growth Factor Receptor Transactivation: Reversal by Gefitinib Pretreatment

A. Ratto, Roberto Würth, A. Bajetto, 2008, Molecular Pharmacology.

An Alu‐like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells

R. Cancedda, M. Robello, Roberta Tasso, 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Ruta graveolens L. Induces Death of Glioblastoma Cells and Neural Progenitors, but Not of Neurons, via ERK 1/2 and AKT Activation

C. Ciniglia, F. Volpicelli, S. Thellung, 2015, PloS one.

Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors

A. Bajetto, T. Florio, F. Barbieri, 2017, Front. Cell. Neurosci..

Canine osteosarcoma cell lines contain stem-like cancer cells: biological and pharmacological characterization.

A. Ratto, S. Thellung, A. Bajetto, 2016, The Japanese journal of veterinary research.

The Chemokine SDF1/CXCL12: A Novel Autocrine/Paracrine Factor Involved In Pituitary Adenoma Development

Roberto Würth, S. Thellung, A. Bajetto, 2011 .

Glioblastoma Cancer Stem Cells: Response to Epidermal Growth Factor Receptor Kinase Inhibitors

Roberto Würth, A. Bajetto, T. Florio, 2011 .

Identification of the hydantoin alkaloids parazoanthines as novel CXCR4 antagonists by computational and in vitro functional characterization.

R. Vitale, P. Amodeo, E. Ioannou, 2020, Bioorganic chemistry.

Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature

Roberto Würth, A. Bajetto, T. Florio, 2011, Journal of Neuroimmunology.

EGFR inhibitors and glioblastoma tumor initiating cells 1 DIFFERENT RESPONSE OF HUMAN GLIOMA TUMOR-INITIATING CELLS TO EGFR KINASE INHIBITORS

A. Bajetto, T. Florio, F. Barbieri, 2009 .

Metformin selectively affects human glioblastoma tumor-initiating cell viability

G. Sambuceti, Roberto Würth, T. Florio, 2013, Cell cycle.